News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
363,888 Results
Type
Article (14430)
Company Profile (115)
Press Release (349343)
Section
Business (112621)
Career Advice (456)
Deals (18610)
Drug Delivery (28)
Drug Development (31171)
Employer Resources (50)
FDA (8793)
Job Trends (7672)
News (172737)
Policy (12355)
Tag
2024 BioCapital Digital (1)
2024 BioForest Digital (6)
2024 BioMidwest Digital (1)
2024 Bio NC Digital (4)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (8)
2024 Biotech Beach Digital (2)
2024 Biotech Beach Standard (3)
2024 Genetown Digital (1)
2024 Genetown Standard (6)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (3)
2024 Pharm Country Standard (2)
2025 Lone Star Bio Digital (3)
2026 BioCapital Elite (1)
2026 Biotech Bay Standard (1)
2026 Genetown Elite (1)
2026 Pharm Country Standard (1)
Academia (1319)
Allergies (38)
Alliances (34770)
ALS (22)
Alzheimer's disease (499)
Antibody-drug conjugate (ADC) (61)
Approvals (8811)
Artificial intelligence (224)
Autoimmune disease (2)
Automation (11)
Bankruptcy (131)
Best Places to Work (6522)
BIOSECURE Act (6)
Biosimilars (9)
Biotechnology (87)
Bladder cancer (21)
Brain cancer (11)
Breast cancer (108)
Cancer (934)
Cardiovascular disease (58)
Career advice (406)
Career pathing (8)
CAR-T (97)
Cell therapy (255)
Cervical cancer (9)
Clinical research (24407)
Collaboration (561)
Compensation (102)
Complete response letters (3)
COVID-19 (1146)
CRISPR (34)
C-suite (125)
Cystic fibrosis (47)
Data (877)
Decentralized trials (1)
Denatured (18)
Depression (14)
Diabetes (93)
Diagnostics (4892)
Digital health (15)
Diversity (4)
Diversity, equity & inclusion (9)
Drug discovery (70)
Drug pricing (13)
Drug shortages (4)
Duchenne muscular dystrophy (19)
Earnings (38525)
Editorial (2)
Employer branding (8)
Employer resources (43)
Events (51092)
Executive appointments (355)
FDA (9357)
Featured Employer (26)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (1)
Funding (445)
Gene editing (80)
Generative AI (23)
Gene therapy (159)
GLP-1 (218)
Government (1232)
Grass and pollen (1)
Guidances (23)
Healthcare (9890)
Huntington's disease (5)
IgA nephropathy (9)
Immunology and inflammation (27)
Indications (11)
Infectious disease (1216)
Inflammatory bowel disease (59)
Inflation Reduction Act (3)
Influenza (31)
Intellectual property (56)
Interviews (51)
IPO (8002)
IRA (8)
Job creations (1434)
Job search strategy (362)
Kidney cancer (3)
Labor market (9)
Layoffs (114)
Leadership (3)
Legal (2520)
Liver cancer (34)
Lung cancer (118)
Lymphoma (55)
Machine learning (2)
Management (17)
Manufacturing (165)
MASH (15)
Medical device (11446)
Medtech (11451)
Mergers & acquisitions (10925)
Metabolic disorders (201)
Multiple sclerosis (24)
NASH (3)
Neurodegenerative disease (24)
Neuropsychiatric disorders (3)
Neuroscience (671)
NextGen: Class of 2025 (3535)
Non-profit (1519)
Northern California (1013)
Now hiring (8)
Obesity (86)
Opinion (75)
Ovarian cancer (39)
Pain (44)
Pancreatic cancer (38)
Parkinson's disease (61)
Partnered (10)
Patents (127)
Patient recruitment (48)
Peanut (26)
People (32659)
Pharmaceutical (16)
Phase I (9006)
Phase II (11014)
Phase III (7146)
Pipeline (456)
Podcasts (36)
Policy (26)
Postmarket research (501)
Preclinical (4060)
Press Release (66)
Prostate cancer (39)
Psychedelics (4)
Radiopharmaceuticals (155)
Rare diseases (128)
Real estate (3358)
Recruiting (20)
Regulatory (9318)
Reports (18)
Research institute (1268)
Resumes & cover letters (68)
Rett syndrome (2)
RNA editing (1)
RSV (20)
Schizophrenia (11)
Series A (81)
Series B (48)
Service/supplier (7)
Sickle cell disease (16)
Southern California (1092)
Special edition (1)
Spinal muscular atrophy (58)
Sponsored (13)
Startups (2505)
State (2)
Stomach cancer (1)
Supply chain (22)
The Weekly (17)
United States (10659)
Vaccines (306)
Venture capitalists (19)
Webinars (7)
Weight loss (34)
Women's health (17)
Worklife (2)
Date
Today (13)
Last 7 days (266)
Last 30 days (1332)
Last 365 days (17670)
2025 (4015)
2024 (18711)
2023 (22098)
2022 (30814)
2021 (32512)
2020 (30537)
2019 (25793)
2018 (19458)
2017 (18872)
2016 (17761)
2015 (20561)
2014 (15177)
2013 (12742)
2012 (13781)
2011 (14066)
2010 (12826)
Location
Africa (318)
Alabama (37)
Alaska (6)
Arizona (118)
Arkansas (10)
Asia (23985)
Australia (4178)
California (2644)
Canada (979)
China (223)
Colorado (153)
Connecticut (126)
Delaware (36)
Europe (49000)
Florida (439)
Georgia (130)
Idaho (33)
Illinois (262)
India (10)
Indiana (151)
Iowa (4)
Japan (96)
Kansas (80)
Kentucky (6)
Louisiana (5)
Maine (20)
Maryland (431)
Massachusetts (1855)
Michigan (178)
Minnesota (238)
Mississippi (2)
Missouri (56)
Montana (24)
Nebraska (15)
Nevada (19)
New Hampshire (66)
New Jersey (833)
New Mexico (16)
New York (786)
North Carolina (500)
North Dakota (7)
Northern California (1013)
Ohio (98)
Oklahoma (11)
Oregon (19)
Pennsylvania (542)
Puerto Rico (7)
Rhode Island (20)
South America (505)
South Carolina (16)
South Dakota (1)
Southern California (1092)
Tennessee (54)
Texas (431)
Utah (97)
Virginia (52)
Washington D.C. (11)
Washington State (307)
West Virginia (3)
Wisconsin (34)
363,888 Results for "nexalin technology".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Nexalin Technology Welcomes General Wesley Clark to Military & Government Advisory Board
February 26, 2025
·
4 min read
Press Releases
Nexalin Technology Announces Initiation of Patient Recruitment for UCSD’s TBI & PTSD Clinical Study Following IRB Approval
March 3, 2025
·
4 min read
Press Releases
Nexalin Technology Announces UCSD IRB Approval for use of HALO™ Clarity in Clinical Trials for mTBI and PTSD Treatment
February 18, 2025
·
5 min read
Press Releases
Join Nexalin Technology’s Exclusive Live Investor Webinar and Q&A Session, Today, January 23
January 23, 2025
·
2 min read
Lone Star Bio
Nexalin Technology Announces Pricing of $5.2 Million Public Offering
Nexalin Technology, Inc. announced the pricing of a public offering of 3,000,000 shares of common stock at public offering price of $1.75.
June 27, 2024
·
3 min read
Lone Star Bio
Nexalin Technology to Present at the Spring MicroCap Rodeo Conference on June 6th
Nexalin Technology, Inc. (the “Company” or “Nexalin”) (Nasdaq: NXL; NXLIW) announced today that it will be participating in the Spring MicroCap Rodeo Conference, that will be held on Thursday, June 6, 2024 in New York City.
June 4, 2024
·
3 min read
Policy
Nexalin Technology Announces Regulatory Approval to Sell Nexalin’s Gen-2, 15 mA Neurostimulation Device by the Brazilian Health Regulatory Agency (Anvisa)
Nexalin Technology, Inc. announced that its second generation, 15 milliamp neurostimulation device has been granted regulatory approval by the Brazilian Health Regulatory Agency, a regulatory body of the Brazilian government responsible for approving new drugs and medical devices.
June 13, 2024
·
3 min read
Press Releases
Nexalin Technology Completes Phase 1of its Innovative Virtual Clinic
December 23, 2024
·
5 min read
Press Releases
Nexalin Appointed as Industry Co-Chair of National TBI Registry Coalition
February 10, 2025
·
3 min read
Lone Star Bio
Join Nexalin Technology’s Exclusive Live Investor Webinar and Q&A Session on May 23
Nexalin Technology, Inc. is pleased to invite investors to a webinar on May 23, 2024, at 4:15 p.m. ET.
May 9, 2024
·
2 min read
1 of 36,389
Next
